NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/28/19

Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three and...

Citing a " strategic shift " in its commercialization approach, NovaBay Pharmaceuticals (NYSEMKT: NBY ) will now sharpen its focus on selling Avenova in areas that have the most volume potential. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

Makes board and executive changes and reduces U.S. sales organization to focus only on high-performing, high potential sales territories and specialty pharmacy channel expansion Company to hold 2018 fourth quarter and full year conference call on March 28, 2019 NovaBay ® Pha...

Gainers: TMSR Holding Company (NASDAQ: TMSR ) +223%.  Integrated Media Technology (NASDAQ: IMTE ) +104% . Titan Pharmaceuticals (NASDAQ: TTNP ) +34%.  Professional Diversity Network (NASDAQ: IPDN ) +30% . Continental Materials (NYSEMKT: CUO ) +29% . Gravity (NASDAQ: GRVY ) ...

This article serves as a portfolio-based market barometer that shows which types of portfolio algorithms are outperforming from week to week. Leveraging different forensic, value, fundamental, momentum, and anomaly portfolios, we may be able to anticipate changes not only in market direction b...